Skip to main content
. 2016 Apr 18;2016(4):CD009747. doi: 10.1002/14651858.CD009747.pub2

Wang 2012.

Methods Design: randomised controlled trial
Randomisation: individual
Trial: daily oral iron versus placebo
Date of study: not stated
Participants Setting: Shanghai
Malaria endemicity: not stated
Included: women of childbearing age, aged 21 years to 45 years (mean age not reported) with anaemia
Excluded: pregnancy
Dropouts: dropout rates not stated
Sample size: total: 69; intervention: 34, control: 35
Interventions Intervention: ferric pyrophosphate and ferrous fumarate (8 mg elemental iron) daily
Control: placebo
Duration: 6 months
Outcomes Haemoglobin, iron status, anaemia
Notes Compliance: not stated
Conflicts of interest: not stated
Funded by: not stated
Other notes: written In Mandarin
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not stated
Allocation concealment (selection bias) Unclear risk Not stated
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Placebo used
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk Not stated. Unlikely that biochemical outcomes affected
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk Not stated
Selective reporting (reporting bias) Unclear risk Not stated
Other bias Low risk Not stated